Yang Jin Selected Research

Member 1 Group F Nuclear Receptor Subfamily 1

5/2022

POU6F1 cooperates with RORA to suppress the proliferation of lung adenocarcinoma by downregulation HIF1A signaling pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yang Jin Research Topics

Disease

57	Neoplasms (Cancer) 06/2022 - 01/2004
29	Inflammation (Inflammations) 03/2022 - 11/2002
17	COVID-19 10/2022 - 01/2020
17	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2003
17	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2010
14	Hyperoxia 01/2020 - 09/2005
9	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2022 - 07/2003
9	Adenocarcinoma of Lung 01/2022 - 10/2007
9	Lung Injury 01/2020 - 01/2005
8	Infections 10/2021 - 10/2014
8	Chronic Obstructive Pulmonary Disease (COPD) 06/2021 - 11/2010
8	Pneumonia (Pneumonitis) 01/2021 - 01/2013
8	Neoplasm Metastasis (Metastasis) 01/2021 - 12/2012
6	Asthma (Bronchial Asthma) 07/2020 - 12/2013
5	Hypoxia (Hypoxemia) 05/2022 - 03/2011
5	Lung Diseases (Lung Disease) 01/2021 - 08/2009
4	Hepatocellular Carcinoma (Hepatoma) 03/2022 - 01/2019
4	Sepsis (Septicemia) 09/2018 - 01/2005
3	Fever (Fevers) 07/2022 - 08/2020
3	Hypersensitivity (Allergy) 11/2021 - 01/2015
3	Emphysema 06/2021 - 11/2010
3	Acute Lung Injury 09/2020 - 02/2009
3	Mood Disorders (Mood Disorder) 11/2019 - 01/2019
3	Lewis Lung Carcinoma 01/2019 - 12/2012
3	Carcinogenesis 01/2018 - 03/2008
3	Typhoid Fever (Typhoid) 08/2008 - 12/2005
2	Disease Progression 07/2022 - 11/2020
2	Bacterial Infections (Bacterial Infection) 01/2022 - 01/2020
2	Vascular System Injuries 11/2021 - 11/2009
2	Carcinoma (Carcinomatosis) 01/2021 - 05/2007
2	Urinary Bladder Neoplasms (Bladder Cancer) 12/2020 - 01/2019
2	Critical Illness (Critically Ill) 12/2020 - 01/2019
2	Tuberculosis (Tuberculoses) 07/2020 - 08/2018
2	Pleural Effusion (Pleural Effusions) 07/2020 - 08/2018

Drug/Important Bio-Agent (IBA)

30	Proteins (Proteins, Gene)FDA Link 05/2022 - 11/2002
15	Biomarkers (Surrogate Marker)IBA 10/2022 - 04/2012
15	CytokinesIBA 10/2022 - 12/2013
10	Biological ProductsIBA 10/2022 - 10/2003
10	Small Interfering RNA (siRNA)IBA 03/2022 - 09/2005
10	MicroRNAs (MicroRNA)IBA 05/2021 - 11/2014
8	Messenger RNA (mRNA)IBA 01/2021 - 11/2002
8	Caveolin 1IBA 07/2015 - 08/2008
7	Pharmaceutical PreparationsIBA 03/2022 - 01/2018
6	Histones (Histone)IBA 01/2021 - 01/2016
6	Long Noncoding RNAIBA 01/2021 - 04/2017
6	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 03/2011
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2017 - 08/2009
6	Interleukin-17 (Interleukin 17)IBA 11/2017 - 01/2014
5	EnzymesIBA 03/2022 - 09/2002
5	LigandsIBA 01/2022 - 01/2003
4	Antiviral Agents (Antivirals)IBA 07/2022 - 01/2020
4	ErbB Receptors (EGF Receptor)IBA 05/2022 - 08/2017
4	Anaplastic Lymphoma KinaseIBA 05/2022 - 01/2018
4	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2018
4	Caspase 3 (Caspase-3)IBA 01/2022 - 07/2003
4	LipidsIBA 01/2021 - 01/2014
4	Tumor Biomarkers (Tumor Markers)IBA 01/2021 - 01/2020
4	LipopolysaccharidesIBA 01/2021 - 02/2009
4	AndrogensIBA 01/2020 - 07/2013
4	SmokeIBA 01/2020 - 11/2010
4	AcidsIBA 01/2020 - 12/2011
4	VaccinesIBA 02/2013 - 12/2005
3	Transcription Factors (Transcription Factor)IBA 05/2022 - 09/2017
3	Activating Transcription Factor 4IBA 01/2022 - 01/2019
3	Nucleic AcidsIBA 10/2021 - 01/2020
3	Hormones (Hormone)IBA 01/2021 - 01/2014
3	InflammasomesIBA 01/2021 - 01/2019
3	Oxygen (Dioxygen)IBA 01/2021 - 01/2005
3	Carcinoembryonic AntigenIBA 08/2020 - 01/2020
3	AntigensIBA 08/2020 - 02/2013
3	IntegrinsIBA 01/2019 - 02/2009
3	Interleukin-8 (Interleukin 8)IBA 11/2017 - 01/2013
3	ChemokinesIBA 03/2015 - 11/2014
3	Peptide Hydrolases (Proteases)FDA Link 03/2015 - 07/2013
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 02/2009 - 11/2002
2	HydrogelsIBA 03/2022 - 11/2015
2	Immune Checkpoint InhibitorsIBA 01/2022 - 03/2020
2	Protein Kinases (Protein Kinase)IBA 01/2022 - 12/2021
2	Phosphotransferases (Kinase)IBA 01/2022 - 12/2021
2	MKC8866IBA 01/2022 - 01/2019
2	Penicillins (Penicillin)FDA Link 11/2021 - 12/2015
2	Cyclic AMP Receptors (Cyclic AMP Receptor)IBA 11/2021 - 09/2020
2	erythromycin propionate-N-acetylcysteinateIBA 11/2021 - 09/2020
2	von Willebrand FactorIBA 11/2021 - 09/2020
2	BilirubinIBA 01/2021 - 01/2020
2	Oncogene Proteins (Oncogene Protein)IBA 01/2021 - 09/2017
2	CateninsIBA 01/2021 - 01/2019
2	Phosphopyruvate Hydratase (Enolase)IBA 01/2021 - 01/2020
2	Blood Glucose (Blood Sugar)IBA 01/2021 - 10/2020
2	AntibodiesIBA 01/2021 - 02/2009
2	CreatinineIBA 01/2021 - 01/2021
2	Indicators and Reagents (Reagents)IBA 01/2021 - 01/2019
2	DNA (Deoxyribonucleic Acid)IBA 08/2020 - 09/2016
2	SilverIBA 08/2020 - 03/2020
2	sanguinarineIBA 07/2020 - 01/2018

Therapy/Procedure

19	Therapeutics 03/2022 - 01/2005
3	Drug Therapy (Chemotherapy) 03/2022 - 01/2006
3	Chinese Traditional Medicine (Traditional Chinese Medicine) 03/2022 - 11/2019
2	Punctures 03/2022 - 12/2013
2	Precision Medicine 01/2021 - 03/2020